Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2630-2639

  Thein, Hla ^a   Haloob, Imad ^b   Marshall, Mark R ^b  

^a WHANGAREI HOSPITAL   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

Dialysate sodium; Haemodialysis; Hypertension; Interdialytic weight gain

Indexed keywords

ANTIHYPERTENSIVE AGENT; BICARBONATE; BICART; SODIUM CHLORIDE; SODIUM ION; UNCLASSIFIED DRUG;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; ARTIFICIAL KIDNEY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMOGRAPHY; DIALYSATE; DIALYSIS MEMBRANE; DIASTOLIC BLOOD PRESSURE; DIFFUSION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FREQUENCY ANALYSIS; HEMODIALYSIS; HUMAN; HYPOTENSION; LINEAR SYSTEM; LONGITUDINAL STUDY; MALE; MULTIVARIATE ANALYSIS; MUSCLE CRAMP; OUTCOMES RESEARCH; POISSON DISTRIBUTION; PREDICTION; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM INTAKE; SODIUM RESTRICTION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

BLOOD PRESSURE; CONFIDENCE INTERVALS; DIALYSIS SOLUTIONS; DIFFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SODIUM; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 34548501282     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm220     Document Type: Article

References (81)

1. Flanigan M. Dialysate composition and hemodialysis hypertension. Semin Dial 2004; 17: 279-283
2. Amerling R, Cu G, Dubrow A et al. Complications during hemodialysis. In: Nissenson A, Fine R, Gentile D, eds. Clinical Dialysis. Appleton & Lange, Norwalk, CN: 1995; 235-267
3. Boquin E, Parnell S, Grondin G et al. Crossover study of the effects of different dialysate sodium concentrations in large surface area, short-term dialysis. Proc Clin Dial Transpl Forum 1977; 7: 48-52
4. Henrich WL, Woodard TD, Blachley JD et al. Role of osmolality in blood pressure stability after dialysis and ultrafiltration. Kidney Int 1980; 18:.480-488
5. Wilkinson R, Barber SG, Robson V. Cramps. Thirst and hypertension in hemodialysis patients - the influence of dialyzate sodium concentration. Clin Nephrol 1977; 7: 101-105
6. Ogden DA. A double blind crossover comparison of high and low sodium dialysis. Proc Clin Dial Transpl Forum 1978; 8: 157-165
7. Stewart WK, Fleming LW, Manuel MA. Muscle cramps during maintenance haemodialysis. Lancet 1972; 1: 1049-1051
8. Charra B, Chazot C, Jean G et al. Role of sodium in dialysis. Minerva Urol Nefrol 2004; 56: 205-213
9. Charra B, Hurot J-M, Chazot C et al. Comparison of survival data. Kidney Int 2000; 58: 901-902
10. Shaldon S. Dietary salt restriction and drug free treatment of hypertension in ESRD patients: A largely abandoned therapy. Nephrol Dial Transplant 2002; 17: 1163-1165
11. Wolcott DL, Maida CA, Diamond R et al. Treatment compliance in end-stage renal disease patients on dialysis. Am J Nephrol 1986; 6: 329-338
12. Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol 2003; 93: P94-p101
13. Brown H, Prescott R. Applied Mixed Models in Medicine. John Wiley & Sons Ltd, Chichester, England: 1999; 79-82
14. Kooman JP, van der Sande F, Leunissen K et al. Sodium balance in hemodialysis therapy. Semin Dial 2003; 16: 351-355
15. Locatelli F, Di Filippo S, Manzoni C. Sodium kinetics during dialysis. Semin Dial 1999; 12 [Suppl]: S41-S4
16. Locatelli F, Ponti R, Pedrini L et al. Sodium kinetics across dialysis membranes. Nephron 1984; 38: 174-177
17. Polaschegg HD, Husar D, inventors. Fresenius AG, assignee. Dialysis Apparatus With Regulated Mixing Of The Dialysis Solution. US patent 4508622. Patent date 02.04.85 Priority DE 21.06.82 3223051 International classification B01D13/00.
18. Gotch F, Evans M, Metzner K et al. An on-line monitor of dialyzer Na and K flux in hemodialysis. ASAIO Trans 1990; 36: M359-m361
19. Ragon A, Reynier JP, Murisasco A et al. Dialysate sodium control during modeling in hemodialysis. Artif Organs 1985; 9: 63-65
20. Cohen J. Statistical power analysis for the behavioral sciences. Lawrence Earlbaum Associates, Hillsdale, NJ: 1988
21. Rosenthal R, Rosnow R. Essentials of Behavioral Research: Methods and Data Analysis. McGraw Hill, New York: 1991
22. Foley R, Parfrey P, Harnett J et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-1385
23. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45: S1-S153
24. Lynn KL. Hypertension and survival in hemodialysis patients. Semin Dial 2004; 17: 270-274
25. Grekas D, Bacharaki D, Goutzaridis N et al. Hypertension in chronic hemodialysis patients: Current view on pathophysiology and treatment. Clin Nephrol 2000; 3: 164-168
26. D'Amico M, Locatelli F. Hypertension in dialysis: Pathophysiology and treatment. J Nephrol 2002; 15: 438-445
27. Shepherd R, Farleigh CA, Atkinson C et al. Effects of haemodialysis on taste and thirst. Appetite 1987; 9: 79-88
28. Matsuoka H, Kimura G, Sanai T et al. Normalization of increased sodium sensitivity by maintenance hemodialysis. Am J Hypertens 1990; 3: 628-631
29. Kimura G, Van Stone JC, Bauer JH. Prediction of postdialysis serum sodium concentration and transcellular fluid shift without measuring body fluid volumes. Artif Organs 1983; 7: 410-415
30. Van Stone JC, Bauer J, Carey J. The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. Am J Kidney Dis 1982; 2: 58-64
31. Moret K, Aalten J, van den Wall Bake W et al. The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: A study in hypotension-prone dialysis patients. Nephrol Dial Transplant 2006; 21: 138-144
32. Charra B, Calemard E, Ruffet M et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-1291
33. Barre PE, Brunelle G, Gascon-Barre M. A randomized double blind trial of dialysate sodium of 145mEq/L, l50mEq/L, and 155 mEq/L. ASAIO Trans 1988; 34: 338-341
34. Daugirdas JT, Al-Kudsi RR, Ing TS et al. A double-blind evaluation of sodium gradient hemodialysis. Am J Nephrol 1985; 5: 163-168
35. Henrich WL, Woodard TD, McPhaul JJ, Jr. The chronic efficacy and safety of high sodium dialysate: Double-blind, crossover study. Am J Kidney Dis 1982; 2: 349-353
36. Song JH, Lee SW, Suh CK et al. Time-averaged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis 2002; 40: 291-301
37. Levin NW, Zhu F, Keen M. Interdialytic weight gain and dry weight. Blood Purif 2001; 19: 217-221
38. Tang HL, Wong SH, Chu KH et al. Sodium ramping reduces hypotension and symptoms during haemodialysis. Hong Kong Med J 2006; 12: 10-14
39. Ebel H, Laage C, Keuchel M et al. Impact of profile haemodialysis on intra-/extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment. Nephron 1997; 75: 264-271
40. Oliver MJ, Edwards LJ, Churchill DN. Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms. J Am Soc Nephrol 2001; 12: 151-156
41. Sang GL, Kovithavongs C, Ulan R et al. Sodium ramping in hemodialysis: A study of beneficial and adverse effects. Am J Kidney Dis 1997; 29; 669-677
42. Fischbach M, Tarral E, Geisert J. Sequential hypertonic haemodialysis in children. Pediatr Nephrol 1988; 2: 442-446
43. Lambie SH, Taal MW, Fluck RJ et al. Online conductivity monitoring: Validation and usefulness in a clinical trial of reduced dialysate conductivity. ASAIO J 2005; 51: 70-76
44. Cybulsky AV, Matni A, Hollomby DJ. Effects of high sodium dialysate during maintenance hemodialysis. Nephron 1985; 41: 57-61
45. Sadowski RH, Allred EN, Jabs K. Sodium modeling ameliorates intradialytic and interdialytic symptoms in young hemodialysis patients. J Am Soc Nephrol 1993; 4: 1192-1198
46. Jenson BM, Dobbe SA, Squillace DP et al. Clinical benefits of high and variable sodium concentration dialysate in hemodialysis patients. Anna J 1994; 21: 115-120; Discussion 21
47. Flanigan MJ, Khairullah QT, Lim VS. Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis 1997; 29: 383-391
48. Levin A, Goldstein MB. The benefits and side effects of ramped hypertonic sodium dialysis. J Am Soc Nephrol 1996; 7: 242-246
49. Dumler F, Grondin G, Levin NW. Sequential high/low sodium hemodialysis: an alternative to ultrafiltration. Trans Am Soc Artif Intern Organs 1979; 25: 351-353
50. Parsons D, Yuill E, Llapitan M et al. Sodium modelling and profiled ultrafiltration in conventional haemodialysis. Nephrology 1997; 3: 177-182
51. Kooman JP, Hendriks EJ, van Den Sande FM et al. Dialysate sodium concentration and blood pressure control in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 554
52. Flanigan MJ. Role of sodium in hemodialysis. Kidney Int 2000; 76 [Suppl]: S72-S78
53. Gotch FA, Lam MA, Prowitt M et al. Preliminary clinical results with sodium-volume modeling of hemodialysis therapy. Proc Clin Dial Transpl Forum 1980; 10: 12-17
54. Zerbe RL, Miller JZ, Robertson GL. The reproducibility and heritability of individual differences in osmoregulatory function in normal human subjects. J Lab Clin Med 1991; 117: 51-59
55. Phillips PA, Bretherton M, Risvanis J et al. Effects of drinking on thirst and vasopressin in dehydrated elderly men. Am J Physiol 1993; 264: R877-R881
56. Robertson JI. Long term reduction in sodium balance. Br Med J 1990; 301: 1159-1160
57. Martinez-Vea A, Garcia C, Gaya J et al. Abnormalities of thirst regulation in patients with chrome renal failure on hemodialysis. Am J Nephrol 1992; 12: 73-79
58. Takamata A, Mack GW, Gillen CM et al. Sodium appetite, thirst, and body fluid regulation in humans during rehydration without sodium replacement. Am J Physiol 1994; 266: R1493- R1502
59. Lopot F, Blaba J, Valek A. An equation for calculating postdialysis plasma sodium. Int J Artif Organs 1992; 15: 354-357
60. de Paula FM, Peixoto AJ, Pinto LV et al. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004; 66: 1732-1238
61. Acchiardo SR, Hayden AJ. Is Na+ modeling necessary in high flux dialysis? ASAIO Trans 1991; 37: M135-M137
62. Bonoinini V, Coli L, Scolari MP. Profiling dialysis: A new approach to dialysis intolerance. Nephron 1997; 75: 1-6
63. Petitclerc T, Jacobs C. Dialysis sodium concentration: What is optimal and can it be individualized? Nephrol Dial Transplant 1995; 10: 596-599
64. Di Filippo S, Corti M, Andrulli S et al. Optimization of sodium removal in paired filtration dialysis by single pool sodium and conductivity kinetic models. Blood Purif 1997; 15: 34-44
65. Di Filippo S, Corti M, Andrulli S et al. Determining the adequacy of sodium balance in hemodialysis using a kinetic model. Blood Purif 1996; 14: 431-436
66. Murisasco A, Leblond G, Elsen R et al. Equilibration of body water distribution and Na+ balance during hemodialysis (HD) with an ion specific electrode feedback system and integrated computer. Trans Am Soc Artif Intern Organs 1984; 30: 254-259
67. Murisasco A, France G, Leblond G et al. Sequential sodium therapy allows correction of sodium-volume balance and reduces morbidity. Clin Nephrol 1985; 24: 201-208
68. Gotch FA, Evans MC, Keen ML. Measurement of the effective dialyzer Na diffusion gradient in vitro and in vivo. Trans Am Soc Artif Intern Organs 1985; 31: 354-358
69. Locatelli F, Di Filippo S, Manzoni C et al. Monitoring sodium removal and delivered dialysis by conductivity. Int J Artif Organs 1995; 18: 716-721
70. Bosetto A, Bene B, Petitclerc T. Sodium management in dialysis by conductivity. Adv Ren Replace Ther 1999; 6: 243-254
71. Ang KS, Benarbia S, Boulahrouz R et al. [Arterial hypertension in the hemodialysis patient. A model of salt-sensitive hypertension in man]. Arch Mal Coeur Vaiss 1999; 92: 1023-1026
72. Krautzig S, Janssen U, Koch K et al. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552-553
73. Charra B. Control of blood pressure in long slow hemodialysis. Blood Purif 1994; 28: 252-258
74. Donohoe P, Farmer C, Dallyn P et al. Low-sodium hemodialysis without fluid removal improves blood pressure control in chronic dialysis patients. Nephrology 2000; 5: 237-241
75. Blaustein MP. Endogenous ouabain: Role in the pathogenesis of hypertension. Kidney Int 1996; 49: 1748-1753
76. Argiles A, Mourad G, Mion C. Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis. N Engl J Med 1998; 339: 1364-1370
77. Argiles A, Lorho R, Servel MF et al. Seasonal modifications in blood pressure are mainly related to interdialytic body weight gain in dialysis patients. Kidney Int 2004; 65: 1795-1801
78. Ozkahya M, Toz H, Qzerkan F et al. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660
79. London GM, Pannier B, Guerin AP et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-2767
80. Fasanella d'Amore T, Wauters JP, Waeber B et al. Salt subtraction in patients on maintenance hemodialysis. Efficacy and limitations. Am J Nephrol 1985; 5: 275-281
81. Nette RW, Krepel HP, van den Meiracker AH et al. Specific effect of the infusion of glucose on blood volume during haemodialysis. Nephrol Dial Transplant 2002; 17: 1275-1280